Stephen Greene, MD

Stephen Greene, MD, is an associate professor of medicine at Duke University School of Medicine and cardiologist at the Duke Clinical Research Institute in Durham, NC. Greene is a member of Practical Cardiology's advisory board and co-host of Don't Miss a Beat, a podcast presented by Inside Cardiology.

Few fields have undergone the evolution seen in heart failure within the past decade. As such, few guidelines have been met with as much anticipation as the 2022 ACC/AHA/HFSA heart failure guidelines. 

Released on April 1, while many were preparing for or already en route to the ACC’s first in-person meeting since 2019, the historic guidelines were released less than a year after the ESC's new heart failure guidelines headlined their 2021 scientific congress. 

In the latest episode of Don’t Miss a Beat, hosts Stephen Greene, MD, of Duke University School of Medicine, and Muthiah Vaduganathan, MD, MPH, of Brigham and Women’s Hospital, breakdown the new joint ACC/AHA/HFSA heart failure guidelines, provide perspective on the recommendations from the viewpoint of practicing cardiologists, and juxtapose the recommendations made in the new guidelines against those made within the ESC 2021 heart failure guidelines.

All episodes of Don’t Miss a Beat are available in an audio-only format on 

Podcasts

In this episode of Don't Miss a Beat, hosts Drs. Greene and Vaduganathan break down the new ACC/AHA/HFSA heart failure guidelines debuted at ACC.22 and compare the recommendations against those made in the European Society of Cardiology's 2021 heart failure guidelines.

Don't Miss a Beat: Interpreting New Heart Failure Guidelines

Every year, the American College of Cardiology (ACC) annual meeting serves as the premier showcase for advancements and discussions around basic science and clinical application of cardiovascular medicine. 

This year, the conference not only represents this showcase of knowledge, but also a major turning point in the battle against COVID-19 as the largest in-person cardiology conference to occur since 2020. With these factors combined, 

ACC.22, which is being held in Washington D.C. and virtually from April 2-4

, is expected to be a celebration of the cardiology community as well as the struggles and triumphs the field has had to endure in the past 2 years.

Headlining this celebration of cardiology will be the multiple late-breaking sessions at this year’s conference. With more than half a dozen sessions dedicated to late-breaking science, attendees are often forced to pick and choose between sessions and other activities on the conference floor. With this in mind, March’s episode of 

 is focused on providing listeners with a preview of the hosts' top picks from late-breaking science slated to be presented at ACC.22.

In the episode, co-hosts Muthiah Vaduganathan, MD, MPH, and Stephen Greene, MD, walk through their picks of top data through the lens of specialists in cardiorenal metabolic diseases. Their picks include SODIUM-HF, PROMPT-HF, SCORED, and DIAMOND. Before diving into their ACC.22 discussion, our hosts also take a moment to expound on the recent announcement from Boehringer Ingelheim and Eli Lilly and Company disclosing their intent to end the phase 3 EMPA-KIDNEY trial early based on the trial’s Independent Data Monitoring Committee’s recommendation.

As a reminder, the audio version of Don’t Miss a Beat is available free on 

Headed to ACC.22 this weekend or following along virtually? Hear from Don't Miss a Beat co-hosts Drs. Vaduganathan and Greene on their top picks from the late-breaking sessions at the upcoming American College of Cardiology meeting.

Don't Miss a Beat: ACC.22 Preview

To refer to Eugene Braunwald, MD, as a pillar in the cardiology community would be underselling his impact on advancing care and research. In the most recent episode of Don't Miss a Beat, co-hosts Muthiah Vaduganathan, MD, MPH, and Stephen Greene, MD, had the privilege of sitting down with Braunwald for a conversation that touches on the founding of the TIMI Study Group, the evolution of clinical trials, and advice he would give to early career professionals with an interest in becoming trialists. 

In the most recent episode of Don't Miss a Beat, co-hosts Drs. Vaduganathan and Greene are joined by Dr. Eugene Braunwald for a conversation that touches on the founding of the TIMI Study Group, the evolution of clinical trials, and advice he would give to early career professionals with an interest in becoming trialists. 

Don't Miss a Beat: Eugene Braunwald, MD, and the TIMI Study Group

Welcome to Don't Miss a Beat presented by Inside Cardiology. Our latest multimedia offering, Don't Miss a Beat was created with Practical Cardiology's mission of providing practicing clinicians with clinically relevant and impactful news within the field of cardiometabolic health in mind. 

Hosted by Stephen Greene, MD, assistant professor of medicine at the Duke University School of Medicine, and Muthiah Vaduganathan, MD, cardiologist at Brigham and Women's Hospital, the monthly podcast will provide a regular news roundup of the latest evidence and clinical trial insights across cardiovascular, renal, and metabolic diseases. 

For those interested in subscribing, Don't Miss a Beat is available on 

Don't Miss a Beat is Practical Cardiology's expert-led podcast. The monthly podcast, which is hosted by Drs. Greene and Vaduganathan, will provide a regular news roundup of the latest evidence and clinical trial insights across cardiovascular, renal, and metabolic diseases.

Stephen Greene, MD

Articles

Don't Miss a Beat: Interpreting New Heart Failure Guidelines

Don't Miss a Beat: ACC.22 Preview

Don't Miss a Beat: Eugene Braunwald, MD, and the TIMI Study Group

Don't Miss a Beat, with Muthiah Vaduganathan, MD, and Stephen Greene, MD